BR112022019794A2 - Derivados de pirrolo[2,3-f]indazol e 2,4,5,10-tetrazatriciclo[7.3.0.03,7]dodeca-1,3(7),5,8,11- penteno como moduladores da alfa-1-antitripsina para tratamento da deficiência de alfa-1-antitripsina (aatd) - Google Patents
Derivados de pirrolo[2,3-f]indazol e 2,4,5,10-tetrazatriciclo[7.3.0.03,7]dodeca-1,3(7),5,8,11- penteno como moduladores da alfa-1-antitripsina para tratamento da deficiência de alfa-1-antitripsina (aatd)Info
- Publication number
- BR112022019794A2 BR112022019794A2 BR112022019794A BR112022019794A BR112022019794A2 BR 112022019794 A2 BR112022019794 A2 BR 112022019794A2 BR 112022019794 A BR112022019794 A BR 112022019794A BR 112022019794 A BR112022019794 A BR 112022019794A BR 112022019794 A2 BR112022019794 A2 BR 112022019794A2
- Authority
- BR
- Brazil
- Prior art keywords
- alpha
- antytripsin
- aatd
- dodeca
- indazole
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
DERIVADOS DE PIRROLO[2,3-F]INDAZOL E 2,4,5,10-TETRAZATRICICLO[7.3.0.03,7]DODECA-1,3(7),5,8,11- PENTENO COMO MODULADORES DA ALFA-1-ANTITRIPSINA PARA TRATAMENTO DA DEFICIÊNCIA DE ALFA-1-ANTITRIPSINA (AATD). Derivados de pirrolo[2,3-f]indazol e 2,4,5,10- tetrazatriciclo[7.3.0.03,7]dodeca-1,3(7),5,8,11-penteno como moduladores da alfa-1 antripsina para tratamento da deficiência de alfa-1 antitripsina (AATD).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063004636P | 2020-04-03 | 2020-04-03 | |
PCT/US2021/025597 WO2021203010A1 (en) | 2020-04-03 | 2021-04-02 | Pyrrolo[2,3-f]indazole and 2,4,5,10-tetrazatricyclo[7.3.0.03,7]dodeca-1,3(7),5,8,11-pentaene derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd) |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112022019794A2 true BR112022019794A2 (pt) | 2022-12-06 |
Family
ID=75690656
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112022019794A BR112022019794A2 (pt) | 2020-04-03 | 2021-04-02 | Derivados de pirrolo[2,3-f]indazol e 2,4,5,10-tetrazatriciclo[7.3.0.03,7]dodeca-1,3(7),5,8,11- penteno como moduladores da alfa-1-antitripsina para tratamento da deficiência de alfa-1-antitripsina (aatd) |
Country Status (13)
Country | Link |
---|---|
US (1) | US20230159580A1 (pt) |
EP (1) | EP4126877A1 (pt) |
JP (1) | JP2023520398A (pt) |
KR (1) | KR20220163429A (pt) |
CN (1) | CN115776984A (pt) |
AR (1) | AR121744A1 (pt) |
AU (1) | AU2021247282A1 (pt) |
BR (1) | BR112022019794A2 (pt) |
CA (1) | CA3179184A1 (pt) |
IL (1) | IL296750A (pt) |
MX (1) | MX2022012095A (pt) |
TW (1) | TW202204359A (pt) |
WO (1) | WO2021203010A1 (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113164761A (zh) | 2018-10-05 | 2021-07-23 | 弗特克斯药品有限公司 | α-1抗胰蛋白酶的调节剂 |
UY38696A (es) | 2019-05-14 | 2020-11-30 | Vertex Pharma | Moduladores de alfa-1 antitripsina |
US20240012010A1 (en) | 2020-11-12 | 2024-01-11 | Vertex Pharmaceuticals Incorporated | Methods of monitoring alpha-1 antitrypsin (aat) deficiency by measuring polymerised aat |
TW202421121A (zh) | 2022-09-09 | 2024-06-01 | 美商維泰克斯製藥公司 | α-1抗胰蛋白酶之調節劑 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3810131A1 (en) * | 2018-06-22 | 2021-04-28 | UCL Business Ltd | Novel compounds |
CN113164761A (zh) * | 2018-10-05 | 2021-07-23 | 弗特克斯药品有限公司 | α-1抗胰蛋白酶的调节剂 |
UY38696A (es) * | 2019-05-14 | 2020-11-30 | Vertex Pharma | Moduladores de alfa-1 antitripsina |
TW202116303A (zh) * | 2019-10-02 | 2021-05-01 | 美商維泰克斯製藥公司 | α—1抗胰蛋白酶缺乏症之治療方法 |
-
2021
- 2021-04-02 BR BR112022019794A patent/BR112022019794A2/pt unknown
- 2021-04-02 IL IL296750A patent/IL296750A/en unknown
- 2021-04-02 US US17/916,481 patent/US20230159580A1/en active Pending
- 2021-04-02 CA CA3179184A patent/CA3179184A1/en active Pending
- 2021-04-02 JP JP2022559584A patent/JP2023520398A/ja active Pending
- 2021-04-02 KR KR1020227038218A patent/KR20220163429A/ko unknown
- 2021-04-02 EP EP21722013.6A patent/EP4126877A1/en active Pending
- 2021-04-02 MX MX2022012095A patent/MX2022012095A/es unknown
- 2021-04-02 CN CN202180039946.7A patent/CN115776984A/zh active Pending
- 2021-04-02 AU AU2021247282A patent/AU2021247282A1/en active Pending
- 2021-04-02 WO PCT/US2021/025597 patent/WO2021203010A1/en active Application Filing
- 2021-04-05 AR ARP210100864A patent/AR121744A1/es unknown
- 2021-04-06 TW TW110112373A patent/TW202204359A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
KR20220163429A (ko) | 2022-12-09 |
MX2022012095A (es) | 2023-01-11 |
JP2023520398A (ja) | 2023-05-17 |
AR121744A1 (es) | 2022-07-06 |
CN115776984A (zh) | 2023-03-10 |
CA3179184A1 (en) | 2021-10-07 |
EP4126877A1 (en) | 2023-02-08 |
WO2021203010A1 (en) | 2021-10-07 |
IL296750A (en) | 2022-11-01 |
AU2021247282A1 (en) | 2022-10-27 |
TW202204359A (zh) | 2022-02-01 |
US20230159580A1 (en) | 2023-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112022019794A2 (pt) | Derivados de pirrolo[2,3-f]indazol e 2,4,5,10-tetrazatriciclo[7.3.0.03,7]dodeca-1,3(7),5,8,11- penteno como moduladores da alfa-1-antitripsina para tratamento da deficiência de alfa-1-antitripsina (aatd) | |
UY38696A (es) | Moduladores de alfa-1 antitripsina | |
CO2021005884A2 (es) | Moduladores de la alfa-1 antitripsina | |
MX2021010888A (es) | Derivados heteroaromaticos y aromaticos heterobiciclicos para el tratamiento de trastornos relacionados con ferroptosis. | |
EA200800006A1 (ru) | Триазолопиридины в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы типа i | |
UY29796A1 (es) | Nuevos compuestos para el tratamiento de trastornos neurológicos, psiquiátricos o del dolor | |
DOP2009000155A (es) | Derivados de hetero-pentaciclo-fenilo fusionados, composicion farmaceutica que los comprende y usos para preparar un medicamento util para el tratamiento de una condicion mediada por p38 | |
AU2018347307A1 (en) | Heterocyclic compounds and uses thereof | |
BR112019001768A2 (pt) | moduladores do receptor de spiro-lactamas nmda e usos dos mesmos | |
GT200500020A (es) | Derivados de 1h-tieno[2,3-c]pirazol utiles como inhibidores de quinasa. | |
GEP20084393B (en) | Aza spiro alkane derivatives as inhibitors of metalloproteases | |
MX2023003677A (es) | Inhibidores de hidroxiesteroide 17beta- deshidrogenasa 13 (hsd17b13) y usos de estos. | |
MX2023009682A (es) | Inhibidores de tyk2 y sus usos. | |
WO2018102687A3 (en) | Combination therapy for treating cancer | |
MX2023003678A (es) | Inhibidores de hidroxiesteroide 17beta- deshidrogenasa 13 (hsd17b13) y usos de estos. | |
MX2023009685A (es) | Inhibidores de tyk2 y sus usos. | |
MX2021002916A (es) | Pirfenidona enriquecida con deuterio y métodos para su uso. | |
MX2023009723A (es) | Inhibidores de tyk2 y sus usos. | |
MX2022000712A (es) | Moduladores de nlrp3. | |
MX2022011829A (es) | Derivados de indol como moduladores de alfa-1-antitripsina para tratar la deficiencia de alfa-1-antitripsina (aatd). | |
MX2023010711A (es) | Fenalquilaminas y métodos de preparación y uso de las mismas. | |
MX2023003675A (es) | Inhibidores de hidroxiesteroide 17beta-deshidrogenasa 13 (hsd17b13) y usos de estos. | |
WO2022053993A3 (en) | Treatments for sars-cov-2 infection (covid-19) | |
WO2021257697A8 (en) | Compounds and methods for blocking apoptosis and inducing autophagy | |
WO2023240253A3 (en) | Modulators of tnf-alpha activity |